Analog Devices beat Wall Street expectations for quarterly revenue on Thursday, driven by upbeat demand for its chips used in the automotive and industrial sectors.
Revenue of $2.64 billion, with double-digit year-over-year growth across all end markets Operating cash flow of $3.9 billion and free cash flow of $3.3 billion on a trailing twelve-month basis or 39%
Analog Devices, Inc. ADI will release its second-quarter earnings results before the opening bell on Thursday, May 22.

Buy Or Sell Analog Devices Ahead Of Earnings?

05:50am, Wednesday, 21'st May 2025
Analog Devices (NASDAQ:ADI) is scheduled to announce its Q2 FY'25 (April 2025) earnings on Thursday, May 22. The consensus estimates revenues of $2.51 billion for the quarter, reflecting a 16% increas
ADI's second-quarter performance is likely to have benefited from inventory normalization, tariff reduction in China and growth across several segments.
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Analog Devices (ADI), delve into some of its key metrics to gain a deeper insight into the company's potential performance for
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
The latest trading day saw Analog Devices (ADI) settling at $226.68, representing a +1.58% change from its previous close.
The 'Undercovered' Dozen series highlights 12 lesser-covered stocks weekly, providing investment ideas and sparking community discussion on their potential. Graham Corporation and Legal & General Grou
Analog Devices is a leading analog electronics company with a diverse portfolio, strong M&A strategy, and significant investments in U.S. manufacturing amid global supply chain issues. Despite a chall
Analog Devices (ADI) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
In the latest trading session, Analog Devices (ADI) closed at $193.72, marking a -0.45% move from the previous day.
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmun
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
WILMINGTON, Mass. , April 24, 2025 /PRNewswire/ --  Analog Devices, Inc.  (Nasdaq:  ADI ) today announced it will release financial results for the second quarter fiscal year 2025 at 7:00 a.m.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE